KYNA is also considered a tumor suppressor due to the inhibition of fibroblast growth factor-1 (FGF-1) release [160], which is involved in MMPs activation, angiogenesis, tumor progression, promotion of cancer cells stemness and is associated with worst patients’ prognosis [161,162,163,164,165,166]. Here, FGF1 is linked to neoplasm.